MedPath

KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1151024002IP

Prescription Type

Uso Hospitalario

Authorization Date

Oct 17, 2019

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1151024002IP
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

PEMBROLIZUMABActive
Quantity: 100 mg
Name: PEMBROLIZUMAB

ATC CLASSIFICATION (3)

L01F
L01FF
L01FF02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.